These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14514140)

  • 1. Implanted pacemaker failure caused by the antirheumatic drug hydroxychloroquine.
    Huang PH; Tuan TC; Lin YJ; Ding YA; Kong CW
    Lupus; 2003; 12(9):725-7. PubMed ID: 14514140
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis.
    Unübol M; Ayhan M; Guney E
    J Clin Rheumatol; 2011 Jan; 17(1):46-7. PubMed ID: 21169846
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxychloroquine-induced hyperpigmentation.
    Cho EB; Kim BC; Park EJ; Kwon IH; Cho HJ; Kim KH; Kim KJ
    J Dermatol; 2012 Oct; 39(10):859-60. PubMed ID: 22671572
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical images: Hydroxychloroquine-associated mucocutaneous hyperpigmentation.
    True DG; Bryant LR; Harris MD; Bernert RA
    Arthritis Rheum; 2002 Jun; 46(6):1698. PubMed ID: 12115210
    [No Abstract]   [Full Text] [Related]  

  • 5. Stevens-Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritis.
    Leckie MJ; Rees RG
    Rheumatology (Oxford); 2002 Apr; 41(4):473-4. PubMed ID: 11961185
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperpigmentation of the skin due to hydroxychloroquine.
    Rood MJ; Vermeer MH; Huizinga TW
    Scand J Rheumatol; 2008; 37(2):158. PubMed ID: 18415776
    [No Abstract]   [Full Text] [Related]  

  • 7. Phototoxic and photoallergic dermatitis caused by hydroxychloroquine.
    Lisi P; Assalve D; Hansel K
    Contact Dermatitis; 2004 Apr; 50(4):255-6. PubMed ID: 15186388
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxychloroquine-induced hyperpigmentation.
    Kasper RS; Flueckiger B; Gobbi S; Lautenschlager S; Borelli S
    J Dtsch Dermatol Ges; 2014 Feb; 12(2):158-61. PubMed ID: 24494645
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for risk of cardiomyopathy with hydroxychloroquine.
    Sumpter MD; Tatro LS; Stoecker WV; Rader RK
    Lupus; 2012 Dec; 21(14):1594-6. PubMed ID: 23036986
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous hyperpigmentation during therapy with hydroxychloroquine.
    Amichai B; Gat A; Grunwald MH
    J Clin Rheumatol; 2007 Apr; 13(2):113. PubMed ID: 17414546
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis.
    Seçkin U; Ozoran K; Ikinciogullari A; Borman P; Bostan EE
    Rheumatol Int; 2000; 19(5):203-4. PubMed ID: 10984140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M
    J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxychloroquine retinopathy: is screening necessary?
    Blyth C; Lane C
    BMJ; 1998 Mar; 316(7133):716-7. PubMed ID: 9529393
    [No Abstract]   [Full Text] [Related]  

  • 14. Blurred vision: targeting a diagnosis.
    Buscombe CP; Lin S; Wilson-Holt NJ
    BMJ; 2013 Sep; 347():f5209. PubMed ID: 24030560
    [No Abstract]   [Full Text] [Related]  

  • 15. Bull's-Eye Maculopathy Associated with Hydroxychloroquine.
    Modi YS; Singh RP
    N Engl J Med; 2019 Apr; 380(17):1656. PubMed ID: 31018071
    [No Abstract]   [Full Text] [Related]  

  • 16. Canadian Consensus Conference on hydroxychloroquine.
    Canadian rheumatology association
    J Rheumatol; 2000 Dec; 27(12):2919-21. PubMed ID: 11128686
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimalarial drugs for rheumatoid disease during pregnancy.
    Koren G
    Can Fam Physician; 1999 Dec; 45():2869-70. PubMed ID: 10626050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missing the bull's eye.
    Gilbert ME; Savino PJ
    Surv Ophthalmol; 2007; 52(4):440-2. PubMed ID: 17574068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.
    O'Dell JR
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S53-8. PubMed ID: 10589358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine-induced restrictive cardiomyopathy: a case report.
    Dogar MU; Shah NN; Ishtiaq S; Shah PN; Shah P; Mathew S; Vittorio TJ
    Postgrad Med J; 2018 Mar; 94(1109):185-186. PubMed ID: 29353247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.